The sequence data were deposited under the study accession PRJEB16012 at the European Nucleotide Archive. The sample accessions are SAMEA4506895 for the case (DS043), SAMEA72802918 for the sire (DS053) and SAMEA72802168 for the dam (DS051).

Introduction {#sec001}
============

The skin and in particular the epidermis provide both an outward and inward barrier function, which is essential for survival. Aberrant skin development or homeostasis can impair this barrier function and may result in skin disorders. Ichthyoses are a heterogeneous group of skin disorders characterized by dry skin, scaling and/or hyperkeratosis, often associated with erythroderma \[[@pgen.1006651.ref001],[@pgen.1006651.ref002]\].These clinical signs are caused by a defect in the terminal differentiation of keratinocytes and subsequent desquamation taking place in the uppermost layer of the epidermis, the stratum corneum. Ichthyoses are primarily inherited skin disorders that can either be non-syndromic, when clinical findings are limited to the skin, or syndromic in case additional organs are involved \[[@pgen.1006651.ref002]\]. Non-syndromic forms of ichthyoses are further sub-classified into common ichthyoses, autosomal recessive congenital ichthyoses, keratinopathic ichthyoses caused by variants in different keratin genes, and other forms of ichthyoses \[[@pgen.1006651.ref001],[@pgen.1006651.ref002]\].

The common ichthyoses consist of ichthyosis vulgaris (IV) and recessive X-linked ichthyosis (RXLI). IV is the most common and mildest form of ichthyosis with an incidence of approximately 1:250 to 1:1000 in humans \[[@pgen.1006651.ref002],[@pgen.1006651.ref003]\]. IV is caused by different semidominant genetic variants in the *FLG* gene encoding filaggrin \[[@pgen.1006651.ref004]\]. Filaggrin ([fil]{.ul}ament [aggr]{.ul}egating prote[in]{.ul}) is a keratin bundling protein and a key player in the formation of the stratum corneum \[[@pgen.1006651.ref005]\]. The precursor of filaggrin is the \>400 kDa protein profilaggrin, which is the major component of keratohyalin granules in the granular layer of the skin \[[@pgen.1006651.ref006],[@pgen.1006651.ref007]\]. Profilaggrin consists of a unique N-terminus and a series of filaggrin units separated by short linker peptides. The initially highly phosphorylated profilaggrin is dephosphorylated and cleaved by proteases into individual filaggrin molecules during the cornification process. In addition to its role in aggregating keratin intermediate filaments into bundles, filaggrin is also degraded into free amino acids that contribute to the hydration of the cornified layer \[[@pgen.1006651.ref008]\].

RXLI, sometimes also called X-linked ichthyosis (XLI), is clinically more severe and characterized by dark brown scales and generalized dry skin. It is caused by variants, mainly large deletions, affecting the *STS* gene, which encodes steroid sulfatase \[[@pgen.1006651.ref009]\].

Autosomal recessive congenital ichthyoses (ARCI) are the second category of non-syndromic ichthyoses. They may be caused by variants in at least 9 different genes: *ABCA12*, *ALOX12B*, *ALOXE3*, *CERS3*, *CYP4F22*, *LIPN*, *NIPAL4*, *PNPLA1* and *TGM1* \[[@pgen.1006651.ref002]\].

Finally, keratinopathic ichthyoses, the third category of non-syndromic ichthyoses, are caused by variants in the *KRT1*, *KRT2*, or *KRT10* genes \[[@pgen.1006651.ref002]\]. Thus, there are currently 14 human genes implicated in different forms of non-syndromic ichthyoses \[[@pgen.1006651.ref002],[@pgen.1006651.ref010]\].

Dogs represent valuable models for many human hereditary diseases and enabled for example the discovery of *PNPLA1* as an ichthyosis gene. The first pathogenic *PNPLA1* variant was identified in Golden Retriever ichthyosis, which is characterized by a mild phenotype. Interestingly, this canine genodermatosis currently has an extremely high prevalence in the breed \[[@pgen.1006651.ref011],[@pgen.1006651.ref012]\]. Other dog models for human non-syndromic ichthyoses include Norfolk Terriers with an epidermolytic ichthyosis caused by a *KRT10* variant \[[@pgen.1006651.ref013]\], Bulldogs with ARCI caused by a *NIPAL4* variant \[[@pgen.1006651.ref014]\], and Jack Russell Terriers with another form of ARCI caused by a *TGM1* variant \[[@pgen.1006651.ref015]\]. Further cases of canine ichthyoses have been reported, but the underlying genetic defects have not been solved \[[@pgen.1006651.ref016]\]. Thus, dogs might help to identify additional ichthyosis genes, which might be of relevance for unsolved human forms of ichthyoses.

In the present study, we describe a novel non-epidermolytic form of ichthyosis in a German Shepherd. In this breed, until now, no ichthyosis cases have been reported in the scientific literature. We therefore applied a whole genome sequencing approach to unravel the causative genetic variant.

Results {#sec002}
=======

Clinical and histopathological phenotype {#sec003}
----------------------------------------

An intact female German Shepherd was presented at 10 months of age with a history of severe scaling of the skin with mild pruritus. According to the owner, the lesions started to develop shortly after birth. Dermatological examination revealed generalized hypotrichosis and focal areas of alopecia with generalized severe exfoliation of greyish scales and mild erythema. Comedones were seen on the ventral abdomen and in the perivulvar area ([Fig 1](#pgen.1006651.g001){ref-type="fig"}).

![Clinical phenotype of the affected German Shepherd.\
**(A)** Hypotrichosis and scaly skin. **(B)** Alopecic region of the thigh with erythema and scales. **(C)** Comedones in the inguinal region. **(D)** Pinna with scales and erythema.](pgen.1006651.g001){#pgen.1006651.g001}

The owner reported that this phenotype had not been seen in the six littermates or the parents of the affected German Shepherd. The skin condition improved under topical treatment with a rehydrating, anti-seborrheic spray and shampoo.

Histopathological analysis of four skin biopsies from different body regions revealed a severe laminar to compact orthokeratotic hyperkeratosis extending into the follicular infundibula in all biopsies. The keratin layers were multifocally exfoliating as large scales. The underlying epidermis was mildly hyperplastic. In the biopsy from the inguinal region, the infundibula of the hair follicles were moderately dilated. The histological findings were consistent with a cornification disorder and an inherited non-epidermolytic ichthyosis as possible cause ([Fig 2](#pgen.1006651.g002){ref-type="fig"}).

![Histopathological findings in skin of the ichthyotic dog and a control dog.\
**(A)** Skin of the ichthyotic dog with severe laminar to compact orthokeratotic hyperkeratosis extending in the follicular infundibula and covering a mildly hyperplastic epidermis. Hematoxylin and Eosin 40x. **(B)** Skin of a normal dog with normal thickness of the epidermis covered by basket-weave orthokeratotic keratin. Hematoxylin and Eosin 40x. **(C,D)** Skin sections of the same dogs as in A and B at higher magnification (100x).](pgen.1006651.g002){#pgen.1006651.g002}

Genetic analysis {#sec004}
----------------

We sequenced the genome of the affected dog at 31x coverage and called SNVs and small indel variants with respect to the reference genome (CanFam 3.1). We then compared these variants to whole genome sequence data of 288 control dogs of various breeds including 13 German Shepherds not closely related to the affected dog ([Table 1](#pgen.1006651.t001){ref-type="table"}). As we did not find any protein-changing variants in the 14 known ichthyosis-associated genes, we hypothesized that the affected dog represented an isolated case of a novel form of ichthyosis. Consequently, we considered both a recessive and a dominant mode of inheritance for the hypothetical mutant allele.

10.1371/journal.pgen.1006651.t001

###### Variants detected by whole genome re-sequencing of the affected dog.

![](pgen.1006651.t001){#pgen.1006651.t001g}

  Filtering step[^a^](#t001fn001){ref-type="table-fn"}                               Number of variants
  ---------------------------------------------------------------------------------- --------------------
  Homozygous variants in the whole genome                                            3,108,583
  Private homozygous variants (absent from 288 control genomes)                      797
  Protein-changing private homozygous variants (absent from 288 control genomes)     4
  Heterozygous variants in the whole genome                                          2,767,699
  Private heterozygous variants (absent from 288 control genomes)                    3,202
  Protein-changing private heterozygous variants (absent from 288 control genomes)   19

^a^ The sequences were compared to the reference genome (CanFam 3.1) from a Boxer.

As purebred dogs are maintained in closed populations with a small effective population size and a considerable degree of inbreeding, recessive genetic defects within a breed typically can be traced back to single founders and are mostly found in homozygous state in affected dogs. In a first analysis, assuming a recessive mode of inheritance, we therefore searched for homozygous private protein-changing variants in the affected dog. Our automated pipeline detected 4 such homozygous protein-changing variants. However, upon individual visual inspection all 4 variants turned out to be sequencing artifacts. They were either located close to gaps in the reference assembly, in highly repetitive sequences, or in regions with low read coverage ([S1 Table](#pgen.1006651.s002){ref-type="supplementary-material"}).

Given that the described dog was the only case in a litter of seven and ichthyosis had never before been reported in the German Shepherd breed, we hypothesized that a dominant mode of inheritance due to a *de novo* mutation event was more likely than a recessive mode of inheritance. In a second analysis, we therefore filtered for heterozygous private protein-changing variants. Our automated pipeline identified 19 such variants in 13 genes. None of the identified variants was located in a known ichthyosis gene. In order to identify potential *de novo* variants, we obtained whole genome sequences from both parents of the affected dogs. Inspection of the sequencing data for each of the 19 heterozygous candidate variants revealed that only one of them was indeed a *de novo* variant ([S1 Table](#pgen.1006651.s002){ref-type="supplementary-material"}).

This *de novo* variant was a missense variant, c.1052T\>C, located in the *ASPRV1* gene encoding "aspartic peptidase, retroviral-like 1" also known as skin aspartic protease (SASPase), which is involved in profilaggrin-to-filaggrin processing \[[@pgen.1006651.ref017],[@pgen.1006651.ref018],[@pgen.1006651.ref022]\]. We performed Sanger sequencing in the affected dog and both parents and confirmed that the variant was absent in both parents ([Fig 3A](#pgen.1006651.g003){ref-type="fig"}). We experimentally confirmed the correct parentage by an analysis of microsatellite and SNV genotypes in the trio.

![Sanger electropherograms of the ASPRV1:c.1052T\>C variant and evolutionary conservation of leucine 351 in the ASPRV1 protein.\
**(A)** A genomic ASPRV1 fragment was amplified by PCR and sequenced with the Sanger method. The figure shows genotypes of the affected daughter and both her non-affected parents. The position of the variant is indicated by an arrow. Note that the variant C-allele is only present in the daughter, but absent from both parents indicating a *de novo* mutation event. **(B)** The leucine residue at position 351 of the canine ASPRV1 protein is strictly conserved in several species and located close to the C-terminal auto cleavage site, which is indicated by arrowheads. The multiple alignment was done using accessions XP_013972931.1 (*Canis lupus familiaris*), NP_690005.2 (*Homo sapiens*), XP_525777.1 (*Pan troglodytes*), XP_014586589.1 (*Equus caballus*), XP_003586694.1 (*Bos taurus*), XP_003354829.2 (*Sus scrofa*), NP_080690.2 (*Mus musculus*) and XP_008761336.1 (*Rattus norwegicus*). A full-length alignment of the proteins from selected species is given in [S1 Fig](#pgen.1006651.s001){ref-type="supplementary-material"}.](pgen.1006651.g003){#pgen.1006651.g003}

The ASPRV1:c.1052T\>C variant is predicted to result in the amino acid substitution p.(Leu351Pro). The leucine at position 351 is strictly conserved among different species of placental mammals and only one residue away from one of the major cleavage sites required for auto-activation of the protein ([Fig 3B](#pgen.1006651.g003){ref-type="fig"}) \[[@pgen.1006651.ref017]\].

Functional confirmation {#sec005}
-----------------------

To assess the putative impact of the ASPRV1 missense variant we performed immunofluorescence staining with anti-ASPRV1 antibodies on skin sections of the affected and a control dog. The ASPRV1 signal in the affected dog showed the expected localization, mainly in the stratum granulosum, but was stronger than in the control dog ([Fig 4](#pgen.1006651.g004){ref-type="fig"}). As this experiment could not assess whether the detected ASPRV1 protein is functional, we also investigated filaggrin processing by immunofluorescence staining with anti-filaggrin antibodies. This experiment demonstrated an abnormal filaggrin expression pattern in the affected dog ([Fig 4](#pgen.1006651.g004){ref-type="fig"}). In the affected dog, diffuse staining across epidermal layers (from stratum basale through stratum spinosum to stratum granulosum) and some nuclear staining indicated defective processing of profilaggrin.

![ASPRV1 and filaggrin protein expression.\
Skin sections of the case and a non-affected control dog were stained for immunofluorescence with an anti-ASPRV1 or anti-filaggrin antibody, respectively. The ASPRV1 signal was stronger in the affected dog than in the control dog. The typical specific expression pattern of filaggrin, a line at the border between stratum granulosum and stratum corneum, was observed in the control dog (bottom panels) but not in the affected dog (third row of panels). Specificity of the antibodies was demonstrated by using rabbit IgG as primary antibody (last column). Scale bars: 25 μm.](pgen.1006651.g004){#pgen.1006651.g004}

Discussion {#sec006}
==========

In the present study we identified a *de novo* missense variant in the canine *ASPRV1* gene in a dog with a novel form of ichthyosis. We provide five arguments supporting the causality of the ASPRV1:c1052T\>C variant for the observed ichthyosis.

First, the c.1052T\>C variant leads to a non-conservative amino acid exchange p.(Leu351Pro) close to the functionally important auto-cleavage site of the ASPRV1 protease. It is thus conceivable that this specific genetic variant might affect the protein function.

Second, the c.1052T\>C was absent from 288 non-affected dogs of different breeds and thus perfectly associated with the disease status.

Third, the affected dog was heterozygous for the variant, but the mutant allele was absent in blood leukocytes of both parents. We therefore confirmed that the variant had arisen by a *de novo* mutation event that must have occurred in either one of the parental germlines or during early embryonic development of the affected dog. While exact numbers on the frequencies of *de novo* mutation events in dogs were not available at the time of this study, an analysis of 10 human trios reported 73 *de novo* mutation events on average per trio \[[@pgen.1006651.ref019]\]. In another study on human *de novo* mutation events, it was shown that only \~1.3% of the *de novo* variants actually represented protein-changing variants \[[@pgen.1006651.ref020]\]. Similar numbers of *de novo* mutation events were observed in cattle \[[@pgen.1006651.ref021]\]. If we assume that these numbers are similar in dogs, one might expect roughly one *de novo* protein-changing variant in any dog on average, which exactly matches our data with one identified protein-changing variant in the affected dog. We deem it unlikely that such an event would coincidentally affect a gene with a known role in filaggrin processing without being causative for the ichthyosis phenotype.

Fourth, we observed a difference in the ASPRV1 protein expression between the affected dog and a control dog. Somewhat surprisingly, the ASPRV1 protein expression was upregulated in the affected dog. Such an upregulation might have been caused by a compensatory mechanism, if the expressed ASPRV1 protein is non-functional as has been reported for other missense variants \[[@pgen.1006651.ref022]\]. Thus, the increased ASPRV1 quantity is at least compatible with a causal role of the ASPRV1 missense variant in the observed ichthyosis.

Finally and as fifth argument, we experimentally confirmed that the filaggrin protein expression pattern was altered in the affected dog suggesting a defect in profilaggrin-to-filaggrin processing. In our opinion and taken together, these arguments prove the causality of the ASPRV1:c1052T\>C variant for the observed ichthyosis beyond any reasonable doubt.

The *ASPRV1* gene and its encoded protease were initially identified in humans and shortly afterwards in mice. ASPRV1 protein expression was only detected in stratified epithelia and was restricted to the stratum granulosum \[[@pgen.1006651.ref017],[@pgen.1006651.ref018]\]. Further studies suggested that ASPRV1 cleaves the linker sequence in profilaggrin. A deficiency of ASPRV1 resulted in a lower level of stratum corneum hydration \[[@pgen.1006651.ref023]\]. Furthermore, high ASPRV1 protein levels were present in several non-neoplastic skin disorders \[[@pgen.1006651.ref017],[@pgen.1006651.ref024]\].

In transgenic mice, aberrant Asprv1 expression resulted in delayed wound closure \[[@pgen.1006651.ref025]\]. *Asprv1* deficient mice (*Asprv1*^*-/-*^) in a C57BL/6J background showed characteristic parallel skin wrinkles or lined grooves parallel to the body axis, but were reported to have normal skin histology and did not show any signs of ichthyosis \[[@pgen.1006651.ref018]\]. The skin of *Asprv1*^*-/-*^ mice in a hairless background (Hos:HR-1) displayed more fine wrinkles and was drier and rougher than in *Asprv1*^*+/-*^ or *Asprv1*^*+/+*^ mice \[[@pgen.1006651.ref023]\]. In addition to an increased number of epidermal cell layers and a lower level of stratum corneum hydration, a decreased amount of filaggrin monomers together with an accumulation of aberrantly processed profilaggrin in the lower stratum corneum was observed in these mice. The total amount and the composition of free amino acids was however not significantly different from control mice \[[@pgen.1006651.ref023]\].

Our results clearly showed an altered filaggrin expression pattern in the skin of an affected dog with the *ASPRV1* variant. Thus, similar to Asprv1 deficient mice, profilaggrin processing appeared to be defective in the affected dog. In contrast to the findings by Matsui et al. \[[@pgen.1006651.ref023]\], we did however not detect an accumulation of incompletely processed filaggrin in the stratum corneum, but rather in the stratum spinosum and stratum granulosum. It remains unclear why the *Asprv1*^*-/-*^ mice did not show an ichthyosis phenotype as the *ASPRV1* mutant dog. Potential explanations include a gain of function effect of the specific canine missense variant or general differences in the homeostasis of the epidermis between mice and dogs.

According to our knowledge, the *ASPRV1* gene has not been associated with any form of ichthyosis in humans. Missense variants in the human *ASPRV1* gene were reported in 5 of 196 Japanese patients with atopic eczema and 2 of 28 control subjects \[[@pgen.1006651.ref023]\]. Two of the identified variants, p.V243A (identified in a control subject) and p.V187I (identified in 3 atopic eczema patients) led to absence or reduction of ASPRV1 activity *in vitro* \[[@pgen.1006651.ref023]\]. Another study failed to find significant associations between *ASPRV1* genetic variants and atopic eczema or clinically dry skin in different cohorts of Caucasian ancestry \[[@pgen.1006651.ref026]\].

In conclusion, with the identification of a dominant *de novo* missense variant in the *ASPRV1* gene of an ichthyotic dog, we present a new candidate gene for ichthyosis. It seems possible that *ASPRV1* variants might also contribute to unsolved human ichthyoses.

Materials and methods {#sec007}
=====================

Ethics statement {#sec008}
----------------

All animal experiments were performed according to the local regulations. The dogs in this study were examined with the consent of their owners. The study was approved by the "Cantonal Committee For Animal Experiments" (Canton of Bern; permits 22/07, 23/10, and 75/16).

Clinical and histopathological examination {#sec009}
------------------------------------------

The affected dog was examined by a board certified veterinary dermatologist in a private specialist clinic and followed up after initiating treatment with a rehydrating, anti-seborrheic spray (Ermidra, Ufamed AG, Sursee, Switzerland) and shampoo (Sebomild P, Virbac AG, Glattbrugg, Switzerland).The absence of a similar phenotype in littermates, parents and ancestors was reported by the owner. Skin biopsies (6 mm) of the case were taken from the flank, thigh, shoulder, and inguinal region and fixed in 10% buffered formalin for 24 hours. Biopsies were processed, embedded in paraffin and sectioned at 4 μm. Skin sections were stained with hematoxylin and eosin. The histopathology was performed by board certified pathologists.

DNA isolation and parentage confirmation {#sec010}
----------------------------------------

We isolated genomic DNA from EDTA blood samples of the affected dog and its parents. We confirmed the parentage by two different approaches: A multiplex PCR with 7 fluorescently labeled microsatellites primer pairs was performed for both parents and the case. Allele sizes were determined on an ABI 3730 capillary sequencer (Life Technologies) and analyzed using the GeneMapper software (Life Technologies). Mendelian transmission of the alleles was confirmed at all 7 loci. The three dogs were additionally genotyped for 173,662 SNVs on the illumina canine_HD chip by GeneSeek/Neogen. We evaluated the parentage using the \--genome and \--mendel commands in plink 1.07 \[[@pgen.1006651.ref027]\]. Both analyses were in agreement with the assumed parentage (\<0.001% genome regions with IBD = 0 for mother and father; 26 Mendel errors for the trio).

Whole genome sequencing of the affected German Shepherd and its parents {#sec011}
-----------------------------------------------------------------------

Illumina PCR-free TruSeq fragment libraries with insert sizes of 350 bp---400 bp were prepared. For the affected dog, 276 million 2 x 150 bp paired-end reads or 31x coverage were obtained on a HiSeq3000 instrument. The parents were sequenced at 21x coverage. The reads were mapped to the dog reference genome assembly CanFam3.1 and aligned using Burrows-Wheeler Aligner (BWA) version 0.7.5a \[[@pgen.1006651.ref028]\] with default settings. The generated SAM file was converted to a BAM file and the reads were sorted using samtools \[[@pgen.1006651.ref029]\]. Picard tools (<http://sourceforge.net/projects/picard/>) was used to mark PCR duplicates. To perform local realignments and to produce a cleaned BAM file, we used the Genome Analysis Tool Kit (GATK version 2.4.9, 50) \[[@pgen.1006651.ref030]\]. GATK was also used for base quality recalibration with canine dbsnp data as training set. The sequence data were deposited under the study accession PRJEB16012 at the European Nucleotide Archive. The sample accessions are SAMEA4506895 for the case (DS043), SAMEA72802918 for the sire (DS053) and SAMEA72802168 for the dam (DS051).

Variant calling {#sec012}
---------------

Putative SNVs were identified in each sample individually using GATK HaplotypeCaller in gVCF mode, and subsequently genotyped per-chromosome and genotyped across all samples simultaneously \[[@pgen.1006651.ref031]\]. Filtering was performed using the variant filtration module of GATK. To predict the functional effects of the called variants, SnpEFF \[[@pgen.1006651.ref032]\] software together with the ENSEMBL (version 80) annotation CanFam 3.1 was used. We additionally visually inspected the short read alignments of the functional candidate genes *ABCA12*, *ALOX12B*, *ALOXE3*, *CERS3*, *CYP4F22*, *FLG*, *KRT1*, *KRT10*, *KRT2*, *LIPN*, *NIPAL4*, *PNPLA1*, *STS*, and *TGM1* in the integrative genome viewer \[[@pgen.1006651.ref033]\] to exclude any structural variants in these genes. We also inspected the *CLDN1* gene in the same manner. For variant filtering we used 288 control genomes, which were either publicly available \[[@pgen.1006651.ref034]\] or produced during other projects of our group. A detailed list of these control genomes is given in [S2 Table](#pgen.1006651.s003){ref-type="supplementary-material"}.

Gene analysis {#sec013}
-------------

We used the dog CanFam 3.1 reference genome assembly for all analyses. Numbering within the canine *ASPRV1* gene corresponds to the accessions XM_014117456.1 (mRNA) and XP_013972931.1 (protein). Numbering within the human *ASPRV1* gene corresponds to the accessions NM_152792.2 (mRNA) and NP_690005.2 (protein).

Sanger sequencing {#sec014}
-----------------

We used Sanger sequencing to confirm the candidate variant c.1052T\>C in *ASPRV1* in the affected dog and its absence in both parents. A 370 bp fragment containing the variant was PCR amplified from genomic DNA using AmpliTaq Gold 360 Master Mix (Life Technologies) and the primers ACCCCAGGGACAGATTAAGG and AGCTGAAGCTGAAGGCAGAG. After treatment with shrimp alkaline phosphatase and endonuclease I, PCR products were directly sequenced on an ABI 3730 capillary sequencer (Life Technologies). We analyzed the Sanger sequence data using the software Sequencher 5.1 (GeneCodes).

Immunofluorescence staining and fluorescence microscopy {#sec015}
-------------------------------------------------------

Immunofluorescence staining was performed on formalin-fixed paraffin-embedded skin sections of an age- and sex-matched control dog and the affected dog with some adaptations as described previously \[[@pgen.1006651.ref035]\]. Briefly, tissue sections were deparaffinized using xylene. For ASPRV1 staining, antigens were retrieved in a microwave oven for 20 min at 95°C in sodium citrate buffer (10 mM sodium citrate, pH 6.0). Blocking was performed for 1.5 hours at room temperature (10% goat serum, 1% BSA, 0.1% Triton X-100; 5% cold fish gelatin in PBS). Tissue sections were incubated with a polyclonal rabbit anti-ASPRV1 antibody (1:250, NBP2-33981, Novus Biological) overnight at 4°C and with the secondary goat anti-rabbit Alexa Fluor 488 nm antibody (1:1000, Abcam) for 1 hour at room temperature. DNA was stained with 4',6-diamidino-2-phenylindole (DAPI) contained in Vectashield Antifade Mounting Medium (Vector Laboratories). For filaggrin staining, antigens were retrieved in a pressure cooker for 15 min in Tris buffer (100 mM) with 5% urea. Blocking was performed for 1.5 hours at room temperature (10% goat serum, 1% BSA, 0.1% Triton X-100; 5% cold fish gelatin in PBS). Tissue sections were incubated with a polyclonal rabbit anti-filaggrin antibody (1:250, PRB-417P-100, Covance) overnight at 4°C and with the secondary goat anti-rabbit Alexa Fluor 488 nm antibody (1:1000, Abcam) for 1 hour at room temperature. DNA was stained with DAPI (1:1000, Sigma Aldrich). Tissue sections serving as negative controls were incubated with rabbit IgG serum. Images were taken with a Nikon Eclipse 80i fluorescence microscope using a Plan Flour x40/10 oil-immersion objective and excitation wavelength of 393 and 488nm. Pictures were captured and further processed using Improvision Open Lab 5.5.2. software.
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======================
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###### Control dogs used for whole genome sequencing.

(XLSX)

###### 

Click here for additional data file.
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